Evaluation of potential immunogenicity differences betweenPandemrix™ andArepanrix™

Antibody dissociation rates are predictive of neutralizing antibody (NAb) course: A comparison of interferon beta-1b-treated Multiple Sclerosis (MS) patients with transient versus sustained NAbs

(2015) Ebrima Gibbs et al.   CLINICAL IMMUNOLOGY

Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2

(2015) Syed Sohail Ahmed et al.   Science Translational Medicine

Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: What is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants

(2014) S. Sohail Ahmed et al.   JOURNAL OF AUTOIMMUNITY

Risk of Narcolepsy Associated with Inactivated Adjuvanted (AS03) A/H1N1 (2009) Pandemic Influenza Vaccine in Quebec

(2014) Jacques Montplaisir et al.   PLoS One

Avidity of Anti-Circumsporozoite Antibodies following Vaccination with RTS,S/AS01E in Young Children

(2014) Ally Olotu et al.   PLoS One

Antigenic Differences between AS03 Adjuvanted Influenza A (H1N1) Pandemic Vaccines: Implications for Pandemrix-Associated Narcolepsy Risk

(2014) Outi Vaarala et al.   PLoS One

Serum IgG titres, but not avidity, correlates with neutralizing antibody response after H5N1 vaccination

(2014) Gabriel Kristian Pedersen et al.   VACCINE

Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials

(2013) Odile Launay et al.   BMC INFECTIOUS DISEASES

Surface plasmon resonance measurements of plasma antibody avidity during primary and secondary responses to anthrax protective antigen

(2013) Heather E. Lynch et al.   JOURNAL OF IMMUNOLOGICAL METHODS

DNA Priming Prior to Inactivated Influenza A(H5N1) Vaccination Expands the Antibody Epitope Repertoire and Increases Affinity Maturation in a Boost-Interval–Dependent Manner in Adults

(2013) Surender Khurana et al.   JOURNAL OF INFECTIOUS DISEASES

Narcolepsy and A(H1N1)pdm09 vaccination

(2013) Robbert van der Most et al.   Human Vaccines & Immunotherapeutics

High Titer and Avidity of Nonneutralizing Antibodies against Influenza Vaccine Antigen Are Associated with Severe Influenza

(2012) Kelvin K. W. To et al.   Clinical and Vaccine Immunology

Development and application of a GuHCl-modified ELISA to measure the avidity of anti-HPV L1 VLP antibodies in vaccinated individuals

(2012) Joseph G. Dauner et al.   MOLECULAR AND CELLULAR PROBES

The incidence of narcolepsy in Europe: Before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns

(2012) Leonoor Wijnans et al.   VACCINE

Narcolepsy with hypocretin/orexin deficiency, infections and autoimmunity of the brain

(2011) Birgitte Rahbek Kornum et al.   CURRENT OPINION IN NEUROBIOLOGY

Immune Response Following H1N1pdm09 Vaccination: Differences in Antibody Repertoire and Avidity in Young Adults and Elderly Populations Stratified by Age and Gender

(2011) Surender Khurana et al.   JOURNAL OF INFECTIOUS DISEASES

MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines

(2011) S. Khurana et al.   Science Translational Medicine

Surface plasmon resonance for vaccine design and efficacy studies: recent applications and future trends

(2010) Stephen Hearty et al.   Expert Review of Vaccines

Safety and Cross‐Reactive Immunogenicity of Candidate AS03‐Adjuvanted Prepandemic H5N1 Influenza Vaccines: A Randomized Controlled Phase 1/2 Trial in Adults

(2010) Joanne M. Langley et al.   JOURNAL OF INFECTIOUS DISEASES

Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes

(2010) Ana Clara Monsalvo et al.   NATURE MEDICINE

Vaccines with MF59 Adjuvant Expand the Antibody Repertoire to Target Protective Sites of Pandemic Avian H5N1 Influenza Virus

(2010) S. Khurana et al.   Science Translational Medicine